Proactive Investors - Run By Investors For Investors

CloudTag given boost as it waits for CES orders to roll in

CloudTag Track is the only device on the market to give a full ECG, which then makes it possible to accurately calculate energy expenditure.
CloudTag given boost as it waits for CES orders to roll in
Feel the burn: The device can be used for fitness and weight loss.

Wearable technology specialist CloudTag (LON:CTAG) has received heartening evidence of backing for its technology following its successful debut at the CES ‘geekfest’ in Las Vegas.

In January, it secured a £1.25mln loan facility from private equity firm Hector Limited that offers the option to convert any amounts drawn down into shares at 2.25p. The loan carries a coupon of 10% and is subject to a 3.7% administration fee.

In early March it achieved the unusual feat of issuing shares at a premium, raising £215,000 through a subscription offer at 1.84p a pop, versus a closing price of 1.725p on the day before the fund-raising announcement.

The cash provides some financial flexibility as it waits from business to flow in from CES, where it launched the CloudTag Track.

CloudTag Track uses grade ECG (Electrocardiography) technology, allowing for accurate assessments of heart rate and energy expenditure. It can be worn on the wrist for daily tracking and on the chest during exercise. A one hour charge gives it life for three to five days.

Good for fitness fanatics, its use can be extended into the weight loss arena where accurate calorie readings are required.

At CES, CloudTag said it spoke to some of the world's largest consumer technology manufacturers, one of Europe's leading sporting goods distributors and two of North America's largest department stores and retail groups. 

It also said it generated business-to-business opportunities with insurance providers and mobile phone operators.

“The directors of CloudTag are confident that several of these opportunities will lead to commercial arrangements and look forward to updating the market in due course as discussions progress further,” the company said in a stock market statement.

“We’re looking to supply the market by end of May, 2016,"  chief executive Amit Ben-Haim told Proactive last week from CES.

The focus is now on getting the production of CloudTag Track and the beatSMART clip to commercial quantities by the second quarter, as the chief exec explains in the video below.


A series of patent applications have been made in the UK to protect the intellectual property, while product validation came via research carried out by the sports performance unit at the University of Essex.

Boss Ben-Haim said: "I am delighted with the very rapid progress made by the team over the past few months ensuring the delivery of our first product to its launch at CES in Las Vegas. 

“The reception at CES was overwhelmingly positive and we are now turning all our attention to closing the commercial opportunities that we expect will lead to firm orders in due course."

Why Invest In CloudTag Inc? Read More Here

Register here to be notified of future CTAG Company articles
View full CTAG profile View Profile

CloudTag Inc Timeline

Big Picture
January 17 2017

Related Articles

eSports player at a Gfinity event
April 13 2017
eSports are tipped to generate more than £1bn a year in a global revenue by 2020, while audience numbers are set to go through the roof too
September 07 2016
The market appears to have been been catching on as well in recent weeks.
Online shopping
January 30 2017
The acquisition of Fredhopper looks a fantastic deal, bringing critical mass to ATTRAQT

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use